3 Undervalued Health Care Equipment & Supplies Stocks for Friday, November 15
Discover the top 3 undervalued Health Care Equipment & Supplies stocks for Friday, November 15 based on AAII’s Stock Grades.Tudor Pop
Stock Evaluator: Bluejay Diagnostics, Inc. (BJDX)
Bluejay Diagnostics, Inc. BJDX
$2.35
0.16
7.31%
November 6, 2026 4:00:00 PM
EST
Volume: 16,921
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Commentary & Analysis
6 Undervalued Health Care Equipment & Supplies Stocks for Friday, October 04
Discover the top 6 undervalued Health Care Equipment & Supplies stocks for Friday, October 04 based on AAII’s Stock Grades.Omar Beirat
5 Undervalued Medical Equipment, Supplies & Distribution Stocks for Tuesday, April 04
Discover the top 5 undervalued Medical Equipment, Supplies & Distribution stocks for Tuesday, April 04 based on AAII’s Stock Grades.Jenna Brashear
Is Bluejay Diagnostics Inc (BJDX) Stock a Good Investment?
Learn more about Bluejay Diagnostics Inc's (BJDX) stock grades for Value, Momentum, Growth and Estimate Revisions and determine whether this Medical Equipment, Supplies & Distribution stock meets your investment needs.Jack Gilleland
Financial Summary
| Share Statistics | BJDX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2.6 | $402.1 | 3% |
|
| Shares Out (Mil) | 0.5 | 40.6 | 3% |
|
| Institutional Ownership | 81.9% | 83.5% | 50% |
|
| Float (Mil) | 1.1 | 35.2 | 3% |
|
| Beta | 0.92 | 0.85 | 55% |
|
| Avg Daily Volume (000s) | 87 | 373 | 35% |
|
| Price Change (52-week) |
(91.5%) | 63.1% | 5% |
|
| Growth | BJDX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | (41.5%) | (5.6%) | 9% |
|
| EPS (5yr) | na | 10.6% | na |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | na | (15.6%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | BJDX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $127 | na |
|
| Net Income (TTM) (Mil) | ($7) | ($9) | 31% |
|
| EPS (TTM) | ($26.591) | ($0.300) | 2% |
|
| Operating Cash Flow (TTM) (Mil) | ($6) | ($1) | 24% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $27 | 0% |
|
| Enterprise Value (Q1) (Mil) | ($7) | $390 | 2% |
|
| Valuation | BJDX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.12 | 2.54 | 3% |
|
| P/E | na | 26.2 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.4 | na |
|
| Ratios | BJDX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 59.5% | na |
|
| Net Margin | na | (4.6%) | na |
|
| ROA | (81.1%) | (10.8%) | 7% |
|
| ROE | (98.9%) | (9.4%) | 9% |
|
| Liabilities to Assets | 18.4% | 46.0% | 12% |
|
| F-Score | 3 | 4 | na |
|
Bluejay Diagnostics, Inc. did not pass any screens on 11/6/2026.
